Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 19-01 

Phase III randomised double blind study of Letrozole versus placebo in women with primary breast cancer completing five or more years of adjuvant Tamoxifen

DESIGN

Design Trial 19-01

Results & Publications


Publications

Study Chair
Prof. Monica Castiglione - Bern, Switzerland

Trial Coordinator
Rita Pfister
IBCSG Coordinating Center, Bern, Switzerland
Phone: +41 31 389 93 91
Fax: +41 31 389 92 73
Email: rita.pfister@ibcsg.org

Date of Activation
September 3, 2001

Date of Closure
May 31, 2002

Targeted Accrual
4800 patients

Final Accrual
5031 patients


Results Publications Results & Publications


News

05.03.2015:
New publications are available 

18.02.2015:
A few impressions from our audits

16.02.2015:
Thank you for your interest in working for IBCSG. Currently we do not have any open positions.

All News

 
  Print